Aim: To evaluate the effects and elucidate the mechanisms of a series of indoloquinazolines as novel anticancer agents. Methods: Condensation of the substituted isatoic anhydride with the substituted isatin was performed to prepare compounds 1-4, followed by adding malononitrile to prepare compounds 5-7. Cytotoxicity was measured by MTT assays. Apoptosis induction was evaluated using DNA fragmentation, cell cycle assay, caspase 3/7 activity and Western blot. Results: Compounds 3, 4, and 5 display cytotoxicity against MCF-7, HeLa, SKOV3, and A498 cancer cells. DNA ladders appear in cells treated with compounds 3, 4, and 5. Within those, compound 4 exhibits the greatest activity in regards to sub-G 1 accumulations in the cell cycle and the activation of caspase-3/7. Furthermore, Fas and Fas ligand levels are elevated by compound 4, implying that the apoptosis is in part mediated through the signals. On the other hand, compounds 1 and 7 display chemosensitizing activity since cytotoxicity of doxorubicine and etoposide is enhanced in combination with compound 1 and 7, respectively, in MCF-7/adr (doxorubicinresistant) and MCF-7/vp (etoposide-resistant). Conclusion: The cytotoxicity of indoloquinazolines is structure-dependent rather than cell type-dependent due to the similar degree of cytotoxicity induced by the individual compounds in all four cell lines. Further modification of the tryptanthrin skeleton is important to develop novel anticancer agents bearing either cytotoxicity against MCF-7 cells or drug resistance reversal in MCF-7/adr and MCF-7/ vp.
Introduction
In the last decade, basic cancer research has produced remarkable advances in our understanding of cancer biology and cancer genetics. Among the most important advances is that apoptosis and the genes that regulate it have a profound effect on the malignant phenotype. For example, it is now clear that some oncogenic mutations interrupt apoptosis, leading to tumor initiation, progression or metastasis. Finally, it is now well documented that most cytotoxic anticancer agents induce apoptosis, raising the possibility in apoptotic programs.
Apoptosis is a form of programmed cell death that plays a fundamental role in many normal biological processes as well as several disease states. Apoptosis can be induced by various stimuli that all produce the same end result: systematic and deliberate cell death [1] . Recent developments strongly implicate a number of central mediators of apoptosis [2] . The cell surface molecule Fas (APO-1/CD95) transduces the intracellular apoptotic death signaling upon stimulation by Fas ligand [3] . Fas plays a dominant role in various physiological cell death and disease states, leading to the caspase 8-dependent activation of effector caspases, such as caspase 3 [4, 5] . Among caspases, an essential role of caspase 3 in Fas-mediated apoptosis has been reported [6] . Caspase 3 exists in the cytoplasm of intact cells as a proenzyme form and is activated by proteolysis induced by the stimulation of Fas [7] . Caspase 3 is the essential factor in Fas-initiated death signaling, since it directly induces the activation of DNA fragmentation factor [8] . Multidrug resistance (MDR) is recognized as the most common cause of failure of cancer chemotherapy. MDR is an overall phenomenon resulting from cross-resistance to a variety of structurally and functionally unrelated natural products such as anthracyclines, Vinca alkaloids, epipodophyllotoxins and taxanes. Chemotherapeutic agents such as doxorubicin can select for mutations leading to increased expression of Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines P-glycoprotein and the phenotype of MDR in tissue culture models [9] . Development of adjuvant agents to overcome multidrug resistance (MDR) becomes a new trend in cancer chemotherapy.
Indigo plants have been a familiar and important source of dye for Asians since ancient times. Honda et al first isolated an indoloquinazoline, tryptanthrin, from Indigo plant Strobilanthes cusia [10] . Tryptanthrin with chemical name indolo [2,1-b] quinazolin-6,12-dione was reported to carry anti-microbial activity against a variety of microorganisms including bacteria, yeasts, dermatophytes and phytopathogens [10, 11] . Recently, tryptanthrin has been paid much attention as an aryl hydrocarbon receptor agonist [12] , anti-inflammatory agent [13] , inducer of caspase-3/Fas mediated apoptosis [14] , cytostatic agent [15] and drug resistance reversal agent [16] . In this study, a series of tryptanthrin derivatives were synthesized and designated as compounds 1-7. Anticancer and chemosensitizing activities were examined in MCF-7 cells. Results showed that compounds 3, 4, and 5 exhibited cytotoxicity at micromolar or lower concentrations. DNA fragmentation and cell cycle progression were determined by treating with compounds 3, 4, and 5. Changes in Fas/Fas ligand and casepase-3/7 activities reveal the anticancer mechanisms involving Fas-mediated apoptosis pathway. On the other hand, compounds 1 and 7 which are not (or mild) cytotoxic are capable of sensitizing drug-resistant MCF-7 cells.
Materials and methods

Chemicals
Synthesis of 6,12-dihydro-6,12-dioxoindolo-[2,1-b]qinazoline (tryptanthrin) and its analogues were as described with modifications [15, 17] . As outlined in Scheme 1, compounds 1-4 were prepared by condensation of the substituted isatoic anhydride with the substituted isatin in N-methylmorpholine, N,N'-diisopropyl carbodiimide and pyridine. The solution of N,N'-diisopropyl carbodiimide in anhydrous pyridine was added with N-methylmorpholine to increase solubility. The resulting solution was added with the substituted isatoic anhydride and substituted isatin, then subjected to reflux at 120-130 °C for 6 h. Compounds 5-7 containing dicyanomethylene substituent were made as showed in Scheme 2 by treating substituted tryptanthrin with malononitrile in DMSO or NaH/THF, and then stirring for 5 h. The structures of tryptanthrin and its analogues were determined by 1 H and 13 C NMR spectra (Bruker AX-400, AX-300 spectrometer, Billerica, MA). The substituents of the tryptanthrin skeleton were systematically modified as in Schemes 1 and 2 ( Figure 1 ), and tabulated in Table 1 .
Cell lines and cell culture MCF-7/wt, MCF-7/adr and MCF-7/vp cell lines were provided by Dr Chih-hsin YANG (National Taiwan University Hospital, Taiwan, China). HeLa, A498, and SKOV3 cell lines were purchased from ATCC (http://www.atcc.org). Cells were maintained in DMEM medium with 10% fetal calf serum and 100 ng/mL penicillin and streptomycin (Invitrogen, Carlsbad, CA) at 37 °C in 5% CO 2 . MCF-7/adr and MCF-7/vp cells were grown in the presence of 0.1 μmol/L of doxorubicin or etoposide that was removed from the medium 1 week before each assay.
Cell survivability assay
To detect growth inhibition by the series of compounds, cells were seeded onto 96-well plates at a density of 5×10 3 /well before compound treatment. Cytotoxicity of the series of compounds in a variety of cell lines was determined using the MTT assay after incubation of cells with these compounds at various concentrations for 3 d. IC 50 (the concentration of 50% inhibition of cell growth) was determined by interpolation of the dose-response curves.
DNA fragmentation MCF-7/wt cells were plated at 4×10 5 cells/well onto each of 6-well plates. After overnight growth, cells were treated with tryptanthrins for various time periods. DNA was extracted by a Wizard ® Genomic DNA Purification Kit (Promega, Madison, WI) and then dissolved in TE buffer. The purified DNA was quantified and equally loaded onto a 2% agarose gel for electrophoresis. The resulting bands were stained with ethidium bromide and visualized under UV light.
Cell cycle analysis
Cells were treated with various concentrations of tryptanthrin derivatives for 1 d, and then harvested by 0.25% trypsin and washed with PBS. Cells (2×10 5 ) were fixed in 70% ice-cold EtOH/PBS for 20 min on ice, and then washed with PBS and incubated in PI solution (69 mmol/L PI, 388 mmol/L sodium citrate, 100 μg/mL RNase A). Then the cells were analyzed immediately using a FACS Caliber (Beckton Dickinson, USA).
Caspase 3/7 assay
Caspase 3/7 activity was measured using the Caspase-glo 3/7 assay kit (Promega, Madison, WI). After treatment with tryptanthrins at different time points, the cells were incubated with Caspase-glo reagent for 1 h in the dark, and the luminescence was measured using a luminometer (Berthold Technologies, Bad Wildbad, Germany). Equal amount of cells were analyzed by counting a parallel set of cells and determining the total cell number for each sample.
Western blot analysis
The MCF-7 cells were treated with 10 -6 mol/L tryptanthrins for various time periods. At the end of each treatment, the cells were trypsinized from the subconfluent monolayers, and their proteins were extracted using CelLytic TM M Cell Lysis Reagent (Sigma-Aldrich, St Louis, MO). The protein concentration of each sample was determined using a Bio-rad protein assay kit (Bio-Rad Laboratories, Hercules, CA). Total cellular proteins (80 μg/lane) were electrophoresized on 10% SDS-polyacrylamide gels and transferred to a PVDF membrane (GE Healthcare, Little Chalfont, Buckinghamshire, UK). Proteins were labeled with primary antibody: anti-Fas B-10 and anti-Fas Ligand (Santa Cruz, Santa Cruz, CA). Immunoreactive bands were detected by anti-mouse HRP or anti-rabbit peroxidaseconjugated secondary antibody (Chemicon, Temecula, CA). Proteins were visualized via enhanced chemiluminescence (ECL detection kit, GE Healthcare, Buckinghamshire, UK). 
Statistical analysis
Results
Effect of tryptanthrin derivatives on inhibition of proliferation in several cancer cell lines Tryptanthrin-derived indoloquinazolines were synthesized by condensation. Compounds 1-4 were prepared via Scheme 1 and compounds 5-7 containing dicyanomethylene substituent were made via Scheme 2. Growth inhibition of the series of compounds at 1 μmol/L was measured in MCF-7, HeLa, A498, and SKOV3 cells (Table 1) . Compounds 3-5 demonstrate higher than 40% inhibition of proliferation in four cell lines. The IC 50 of compounds 3-5 is lower than 1×10 -6 mol/L in four cell lines among which A498 and MCF-7 are more sensitive to the compounds. Compound 4 is the most potent tryptanthrin derivative presenting cytotoxic activity. The IC 50 is 3.10×10 -7 mol/L in A498 and 3.9×10 -7 mol/L in MCF-7, respectively ( Table 2) .
Apoptotic biomarkers in MCF-7 cells treated with compounds 3-5 DNA fragmentation is a characteristic feature of apoptosis. Fragmented DNA, subjected to electrophoresis on an agarose gel, is in a manner of ladders, suggesting the formation of nucleosomes in apoptosis progress. When MCF-7 cells were treated with compound 4 at 10 -6 mol/L for 6 h, DNA ladders appeared. The intensity of the ladders significantly increased after the cells were longer exposed to compound 4 up to 9 h (Figure 2A) . A delayed appearance (up to 40-44 h) of the DNA ladders was shown in cells treated compounds 3 or 5.
Cell cycle analysis of MCF-7 cells was performed after 24 h of incubation with compounds 3, 4, or 5 at 10 -6 mol/L. As compared to the untreated cells, compounds 3 and 5 did not induce considerable cell cycle arrest, while an important sub-G 1 peak appeared in cells treated with compound 4 at 10 -6 mol/L for 24 h ( Figure 2B) .
Activity of caspase-3/7 which is essential for apoptosis was determined in MCF-7 cells treated with compounds 3, 4, and 5. After exposure to compound 4 at 10 -6 mol/L for 36 h, caspase-3/7 activity was elevated about five folds, compared to the control ( Figure 2C ). Only a slight increase in caspase-3/7 activity was observed in cells with compound 3 or 5.
Changes in Fas and Fas ligand levels in MCF-7 cells treated with compound 4
To verify if compound 4-induced apoptosis was mediated Cell viability was determined using the MTT assay. Data are presented as mean±SD of triplicate determinations. Figure  3 ).
Effect of tryptanthrin and its derivatives in drug-resistant MCF-7 cells
Instead of compouds 3-5 bearing cytotoxicity through activation of apoptosis process, the rest tryptanthrin derivatives, compounds 1, 2, 6, and 7, were not as potent as to inhibit cell proliferation. The IC 50 of compound 1 was 8.23 μmol/L and compounds 2, 6, and 7 existed greater than 10 μmol/L of IC 50 in MCF-7 cells, compared to doxorubicin of which the IC 50 was 0.14 μmol/L in MCF-7 cells. In terms of non-cytotoxic agents, compounds 1, 2, 6, and 7 did not or slightly show growth inhibition in neither MCF-7 nor MCF-7/adr cells (Table 3) . However, in combination with doxorubicin, compounds 1 and 7 at 10 -6 mol/L enhanced growth inhibition activity of doxorubicin in MCF-7/adr cells from 19% to 63% and 53%, respectively. Etoposide which is also a cytotoxic agent is capable of inducing drug resistance in MCF-7 cells, named MCF-7/vp. MCF-7/vp cells were still viable when the cells were treated with compound 1, 7, or etoposide, while the cells turned out to be sensitive to the combination of either compound 1 plus etoposide or compound 7 plus etoposide at concentrations of 1 μmol/L of each (Figure 4) . Compound 7 raised a higher chemosensitizing activity than compound 1 in MCF-7/vp cells. On the contrary, MCF-7/adr cells are more susceptible to compound 1 for enhancing cytotoxicity of doxorubicin.
Similar to compounds 1 and 7, a known MDR reversing agent verapamil at 10 -5 mol/L did not exist cytotoxicity though, it enhanced cytotoxicity of doxorubincin and etoposide in MCF-7/adr and MCF-7/vp, respectively, with various degrees.
Disscussion
Tryptanthrin and its derivatives have been reported to exhibit anticancer effects [15, 17] . In this study, we synthesized a series of tryptanthrin-derived indoloquinazolines, designated as compounds 1-7 and screened for anticancer activity. Compouds 1-4 were prepared by condensation as shown in Scheme 1 and compounds 5-7 containing dicyanomethylene substituents were made via Scheme 2. Among those, either compound 3 bearing an iodine substituent at R 3 or compound 4 with nitrogen containing A ring demonstrated effective growth inhibition activity. The oxygen or dicyanomethylene substitution at Y was indifferent to the cytotoxicity in four cell lines. In fact, the malononitrile derivatives, including compounds 5-7 with dicyanomethylene substitution at Y, exhibited various degree of cytotoxicity. Methoxy group at R 1 and R 2 or chlorine at R 1 did not influence the growth inhibition activity. According to structure-activity relationship analysis, modification of tryptanthrin skeleton with substituents in A ring or D ring enhances the cytotoxicity, except the dimethoxy substitution in A ring. Nitrogen-containing A ring seems to be important to increase cytotoxicity. The cytotoxicity is structure-dependent rather than cell line-dependent because a compound presents similar degree of cytotoxicity in all four cell lines. Tryptanthrin derivatives exhibited double-stranded DNA binding activity [17] , which may in part account for structure-dependent cytotoxicity.
Although the tryptanthrin derivatives are not as potent as doxorubicin to kill the cancer cells, compounds 3-5 exhibit growth inhibition (40%-77%) activity in MCF-7, HeLa, A498, and SKOV3 cells. The apoptotic biomarkers, including DNA fragmentation, elevated sub-G 1 accumulation and an increase in caspase 3/7 activity, appear in the cells treated with compounds 3-5 with various intensities. Among them, compound 4 is of most importance. Mechanisms other than apoptosis may be involved in cell growth inhibition by compounds 3 and 5. The MCF-7 cell line which has been described to be Fas-sensitive [18] undergoes apoptosis through Fas/Fas ligand activation. The Fas/Fas ligand system is a key signaling transduction pathway of apoptosis in cells and tissues. Engagement of Fas by a Fas-ligand lead to the formation of a protein complex known as death-inducing signaling complex and permit acute execution of apoptosis by caspase-8 activation [19] . Reimer et al [20] reported that the selection process leading to highly aggressive breast tumor variants might be enhanced by Fas ligand-mediated tumor fratricide, eventually a possible target for novel therapeutic strategies. Our results show the consistent elevation of Fas ligand levels by treating compound 4 in different time periods (4 and 8 h), in spite of the various levels of Fas with time. Elevation of Fas ligand levels may be important to engage Fas and activate the Fas/Fas ligand-mediated apoptosis afterwards. Results may suggest that compound 4 resents cytotoxicity in part through Fas/Fas ligand pathway. It is possible of crosstalk between extrinsic pathway and intrinsic pathway through mitochondria. It would be worth examining if tryptanthrin derivatives induce mitochondria-related signals such as cytochrome c, caspase 9, etc. To differentiate activity of caspase 8 from caspase 9 enables us to confirm which pathway induced by compound 4. It would be interesting to check this issue in the future experiments.
Resistance to chemotherapy has been remaining a major cause of treatment failure in cancer patients. Development of adjuvant agents to circumvent MDR becomes a new trend in cancer chemotherapy. Many attempts, such as inhibition of MDR-related genes, to overcome MDR have been proposed [21] . Inhibition of MDR1 gene function, either by blocking P-gp function or inhibiting MDR1 gene expression, has been one of the most extensive studies [22, 23] . In this report, compounds 1 and 7 in combination with cytotoxic agents such as doxorubicin and etoposide enhance cytotoxicity of the cytotoxic agents against drug-resistant MCF-7 cells. It suggests that compounds 1 and 7 can sensitize drug-resistant cells to the cytotoxic agents, which may contribute to reverse multidrug resistance. It is still unclear the mechanisms involved in MDR reversal. As compound 1 largely sensitizes MCF-7/adr rather In summary, tryptanthrin-derived indoloquinazolines synthesized in this study undergo multiple ways to display their anticancer activity via inducing cytotoxicity against MCF-7 cells by compounds 3-5 or evoking resistance reversal activity by compounds 1 and 7 in MCF-7/adr and MCF-7/vp cells. Further modification of the tryptanthrin skeleton, based on the structure-activity relationships sketched in this study, becomes important to develop novel anticancer agents bearing either cytotoxicity or resistance reversal activity.
